Correlation Between NewAmsterdam Pharma and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Gain Therapeutics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Gain Therapeutics.
Diversification Opportunities for NewAmsterdam Pharma and Gain Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between NewAmsterdam and Gain is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Gain Therapeutics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Gain Therapeutics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to under-perform the Gain Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, NewAmsterdam Pharma is 2.04 times less risky than Gain Therapeutics. The stock trades about -0.37 of its potential returns per unit of risk. The Gain Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 244.00 in Gain Therapeutics on November 9, 2024 and sell it today you would earn a total of 20.00 from holding Gain Therapeutics or generate 8.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Gain Therapeutics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Gain Therapeutics |
NewAmsterdam Pharma and Gain Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Gain Therapeutics
The main advantage of trading using opposite NewAmsterdam Pharma and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| Gain Therapeutics vs. Biovie Inc | Gain Therapeutics vs. In8bio Inc | Gain Therapeutics vs. NewAmsterdam Pharma | Gain Therapeutics vs. Cue Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |